Login / Signup

Fibroblast GSK-3α Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart.

Prachi UmbarkarSultan TousifAnand Prakash SinghJoshua C AndersonQinkun ZhangMichelle D TallquistJames WoodgettHind Lal
Published in: Circulation research (2022)
GSK-3α-mediated MEK-ERK activation is a critical profibrotic signaling circuit in the injured heart, which operates independently of the canonical TGF-β1-SMAD3 pathway. Therefore, strategies to inhibit the GSK-3α-MEK-ERK signaling circuit could prevent adverse fibrosis in diseased hearts.
Keyphrases
  • pi k akt
  • signaling pathway
  • cell proliferation
  • epithelial mesenchymal transition
  • transforming growth factor
  • atrial fibrillation
  • adverse drug